SPAN DIAGNOSTICS | GOCL CORPORATION | SPAN DIAGNOSTICS/ GOCL CORPORATION |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 16.5 | 30.0 | 54.9% | View Chart |
P/BV | x | - | 1.3 | - | View Chart |
Dividend Yield | % | 0.0 | 1.1 | - |
SPAN DIAGNOSTICS GOCL CORPORATION |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
SPAN DIAGNOSTICS Mar-24 |
GOCL CORPORATION Mar-24 |
SPAN DIAGNOSTICS/ GOCL CORPORATION |
5-Yr Chart Click to enlarge
|
||
High | Rs | 18 | 640 | 2.8% | |
Low | Rs | 9 | 292 | 3.0% | |
Sales per share (Unadj.) | Rs | 22.6 | 144.0 | 15.7% | |
Earnings per share (Unadj.) | Rs | 1.4 | 9.7 | 14.7% | |
Cash flow per share (Unadj.) | Rs | 4.4 | 12.3 | 36.2% | |
Dividends per share (Unadj.) | Rs | 0 | 4.00 | 0.0% | |
Avg Dividend yield | % | 0 | 0.9 | 0.0% | |
Book value per share (Unadj.) | Rs | -3.5 | 286.3 | -1.2% | |
Shares outstanding (eoy) | m | 5.46 | 49.57 | 11.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.6 | 3.2 | 18.4% | |
Avg P/E ratio | x | 9.4 | 47.9 | 19.7% | |
P/CF ratio (eoy) | x | 3.0 | 38.0 | 8.0% | |
Price / Book Value ratio | x | -3.9 | 1.6 | -239.3% | |
Dividend payout | % | 0 | 41.1 | 0.0% | |
Avg Mkt Cap | Rs m | 74 | 23,102 | 0.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 23 | 658 | 3.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 123 | 7,136 | 1.7% | |
Other income | Rs m | 20 | 2,355 | 0.9% | |
Total revenues | Rs m | 144 | 9,490 | 1.5% | |
Gross profit | Rs m | 11 | -126 | -9.1% | |
Depreciation | Rs m | 16 | 125 | 13.2% | |
Interest | Rs m | 7 | 1,463 | 0.5% | |
Profit before tax | Rs m | 8 | 641 | 1.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 158 | 0.1% | |
Profit after tax | Rs m | 8 | 483 | 1.6% | |
Gross profit margin | % | 9.3 | -1.8 | -526.3% | |
Effective tax rate | % | 2.3 | 24.7 | 9.1% | |
Net profit margin | % | 6.3 | 6.8 | 93.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 121 | 14,444 | 0.8% | |
Current liabilities | Rs m | 270 | 2,047 | 13.2% | |
Net working cap to sales | % | -121.1 | 173.7 | -69.7% | |
Current ratio | x | 0.4 | 7.1 | 6.3% | |
Inventory Days | Days | 153 | 598 | 25.7% | |
Debtors Days | Days | 460 | 401 | 114.7% | |
Net fixed assets | Rs m | 113 | 13,244 | 0.8% | |
Share capital | Rs m | 55 | 99 | 55.1% | |
"Free" reserves | Rs m | -73 | 14,091 | -0.5% | |
Net worth | Rs m | -19 | 14,190 | -0.1% | |
Long term debt | Rs m | 34 | 10,745 | 0.3% | |
Total assets | Rs m | 238 | 28,873 | 0.8% | |
Interest coverage | x | 2.1 | 1.4 | 146.3% | |
Debt to equity ratio | x | -1.8 | 0.8 | -238.9% | |
Sales to assets ratio | x | 0.5 | 0.2 | 209.9% | |
Return on assets | % | 6.3 | 6.7 | 93.9% | |
Return on equity | % | -41.4 | 3.4 | -1,216.5% | |
Return on capital | % | 99.6 | 8.4 | 1,181.0% | |
Exports to sales | % | 0 | 4.3 | 0.0% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | 310 | 0.0% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 310 | 0.0% | |
Fx outflow | Rs m | 0 | 128 | 0.0% | |
Net fx | Rs m | 0 | 182 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 25 | 400 | 6.3% | |
From Investments | Rs m | 1 | 7,345 | 0.0% | |
From Financial Activity | Rs m | -21 | -8,004 | 0.3% | |
Net Cashflow | Rs m | 5 | -259 | -2.0% |
Indian Promoters | % | 63.5 | 0.0 | - | |
Foreign collaborators | % | 0.6 | 72.8 | 0.8% | |
Indian inst/Mut Fund | % | 0.0 | 1.7 | - | |
FIIs | % | 0.0 | 0.1 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 36.0 | 27.2 | 132.4% | |
Shareholders | 2,072 | 36,353 | 5.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare SPAN DIAGNOSTICS With: PIDILITE INDUSTRIES SRF BALAJI AMINES YASHO INDUSTRIES NAVIN FLUORINE
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | SPAN DIAGNOSTICS | GULF OIL CORP |
---|---|---|
1-Day | -4.94% | -2.47% |
1-Month | -13.78% | -10.12% |
1-Year | 60.52% | -31.60% |
3-Year CAGR | 28.91% | 8.14% |
5-Year CAGR | 16.17% | 5.26% |
* Compound Annual Growth Rate
Here are more details on the SPAN DIAGNOSTICS share price and the GULF OIL CORP share price.
Moving on to shareholding structures...
The promoters of SPAN DIAGNOSTICS hold a 64.0% stake in the company. In case of GULF OIL CORP the stake stands at 72.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SPAN DIAGNOSTICS and the shareholding pattern of GULF OIL CORP.
Finally, a word on dividends...
In the most recent financial year, SPAN DIAGNOSTICS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
GULF OIL CORP paid Rs 4.0, and its dividend payout ratio stood at 41.1%.
You may visit here to review the dividend history of SPAN DIAGNOSTICS, and the dividend history of GULF OIL CORP.
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.